Albany, NY -- (SBWIRE) -- 05/14/2015 -- According to the EU JPND, neurodegenerative diseases refer to conditions that involve the neurons in the brain. These conditions can affect balance, movement, speech, and respiratory and cardiac functions. They can be inherited or be of unknown etiology. Neurodegenerative diseases are incurable and are severely debilitating. They result in progressive degeneration of nerve cells, causing them to die eventually. These diseases cause ataxia and dementia in people, which can have a serious impact on the mental health of patients. Some examples of neurodegenerative diseases are Alzheimers disease, Parkinsons disease, Huntingtons disease, multiple sclerosis, amyotrophic lateral sclerosis, and epilepsy. Huntingtons disease and amyotrophic lateral sclerosis are rare diseases, unlike Alzheimers disease and Parkinsons disease which have a high degree of prevalence.

Market analysts forecast the global neurodegenerative diseases market to grow at a CAGR of 4.77 percent over the period 2014-2019.

Browse Detail Report With TOC
http://www.researchmoz.us/global-neurodegenerative-diseases-market-2015-2019-report.html

Covered in this report

This report covers the present scenario and the growth prospects of the global neurodegenerative diseases market for the period 2015-2019. To calculate the market size, the report considers revenue generated from the sales of various drugs used in the treatment of neurodegenerative diseases. The market includes data from the sales of various drugs used in the treatment of:

Alzheimer's Disease
Parkinson's Disease
Multiple Sclerosis
Epilepsy
Huntington's Disease
Amyotrophic Lateral Sclerosis

The report also presents the vendor landscape and a corresponding detailed analysis of the top vendors in the global neurodegenerative diseases market. The vendor landscape section includes a market share analysis of the major vendors along with the performances of their product portfolios. In addition, it discusses the major drivers that influence the growth of the market. It also outlines the challenges faced by vendors and the market at large, as well as the key trends that are emerging in the market. In addition, late-stage pipeline molecules developed for the treatment of neurodegenerative diseases are discussed.

Request for Sample Report
http://www.researchmoz.com/enquiry.php?type=sample&repid=278102

New report, Global Neurodegenerative Diseases Market 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas, the EMEA, and the APAC; it also covers the global neurodegenerative diseases market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market.

Key regions

Americas
APAC
EMEA

Key vendors

Biogen Idec
Merck Serono
Novartis
Pfizer
Teva Pharmaceutical Industries
UCB

Other prominent vendors

AB Science
Abbvie
Acorda Therapeutics
Actavis
Active Biotech
Adamas Pharmaceuticals
Akorn
Archer Pharmaceuticals
Astellas
Auspex Pharmaceuticals
Bayer
Boehringer Ingelheim
Covis
Desitin Arzneimittel
Eisai
Eli Lilly
Endo International
F. Hoffmann-La Roche
FORUM Pharmaceuticals
GlaxoSmithKline
Glenmark
H. Lundbeck
Ipsen
Janssen Pharmaceuticals
Kyowa Hakko Kirin
Mitsubishi Tanabe
MorphoSys
Newron Pharmaceuticals
Omeros
Opexa
Orion
Otsuka Pharmaceutical
Oxford BioMedica
Palobiofarma
Prana Biotechnology
Raptor Pharmaceutical
Sanofi
Siena Biotech
SOM Biotech
STADA
Takeda Pharmaceutical
TauRx Pharmaceuticals
US WorldMeds
Valeant
Zinfandel Pharmaceuticals

Market driver

High unmet medical needs
For a full, detailed list, view our report

Market challenge

Generic erosion
For a full, detailed list, view our report

Market trend

Reformulation of marketed drugs
For a full, detailed list, view our report

Key questions answered in this report

What will the market size be in 2019 and what will the growth rate be?
What are the key market trends?
What is driving this market?
What are the challenges to market growth?
Who are the key vendors in this market space?
What are the market opportunities and threats faced by the key vendors?
What are the strengths and weaknesses of the key vendors?

For Market Research Latest Reports Visit
http://www.researchmoz.us/latest-report.html

Table of Content

01. Executive Summary

02. List of Abbreviations

03. Scope of the Report
03.1 Market Overview
03.2 Product Offerings

04. Product Profiles
04.1.1 Avonex/Rebif
04.1.2 Plegridy
04.1.3 Tecfidera
04.1.4 Tysabri
04.1.5 Comtan
04.1.6 Stalevo
04.1.7 Exelon/Exelon Patch
04.1.8 Extavia
04.1.9 Gilenya
04.1.10 Cerebyx
04.1.11 Dilantin-125
04.1.12 Lyrica
04.1.13 Neurontin
04.1.14 Zarontin
04.1.15 Azilect
04.1.16 Copaxone
04.1.17 Keppra/Keppra XR
04.1.18 Neupro
04.1.19 Vimpat
05. Market Research Methodology
05.1 Market Research Process
05.2 Research Methodology

Browse Our Press Releases on Prweb
http://www.prweb.com/search.aspx?search-releases=researchmoz&x=0&y=0

06. Introduction

07. Market Landscape
07.1 Market Overview
07.2 Market Size and Forecast
07.3 Five Forces Analysis

08. Segmentation of Global Neurodegenerative Diseases Market by Type of Disease

09. Global Multiple Sclerosis Market
09.1 Multiple Sclerosis: Overview
09.1.1 About the Disease
09.1.2 Symptoms
09.1.3 Etiology
09.1.4 Epidemiology
09.1.5 Economic Burden
09.2 Market Overview
09.3 Market Size and Forecast
09.4 Multiple Sclerosis Market in US
09.4.1 Market Size and Forecast

Related Reports

Sepsis - Pipeline Review, H1 2015

(http://www.researchmoz.us/sepsis-pipeline-review-h1-2015-report.html)

Global Markets Direct's, 'Sepsis Pipeline Review, H1 2015', provides an overview of the Sepsis's therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Sepsis, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA)...

Ischemic Stroke - Pipeline Review, H1 2015

(http://www.researchmoz.us/ischemic-stroke-pipeline-review-h1-2015-report.html)

Global Markets Direct's, 'Ischemic Stroke Pipeline Review, H1 2015', provides an overview of the Ischemic Stroke's therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Ischemic Stroke, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA),...

For More Reports Browse
https://www.linkedin.com/today/author/68229468

About ResearchMoz
ResearchMoz is the one stop online destination to find and buy market research reports & Industry Analysis. We fulfill all your research needs spanning across industry verticals with our huge collection of market research reports. We provide our services to all sizes of organizations and across all industry verticals and markets. Our Research Coordinators have in-depth knowledge of reports as well as publishers and will assist you in making an informed decision by giving you unbiased and deep insights on which reports will satisfy your needs at the best price.

For More Information Kindly Contact:
Tel: 518-618-1030
Toll Free: 866-997-4948
State Tower
90 State Street, Suite 700
Albany, NY 12207
United States
Email: sales@researchmoz.us